Citation Impact
Citing Papers
Role of Genotype in the Cycle of Violence in Maltreated Children
2002 StandoutScience
Serotonin Transporter Genetic Variation and the Response of the Human Amygdala
2002 StandoutScience
The MacArthur Treatment Competence Study. III: Abilities of patients to consent to psychiatric and medical treatments.
1995
Antidepressant Drug Effects and Depression Severity
2010 Standout
Anaesthesia, surgery, and challenges in postoperative recovery
2003 Standout
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression
2005
Depression
2018 Standout
Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders
1998
Placebo Response in Studies of Major Depression
2002
Competence to consent to treatment as a psycholegal construct.
1984
Are Suicide Attempters Who Self-Mutilate a Unique Population?
2001
5-Hydroxytryptamine pathways in anxiety and its treatment
1995
D2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5‐hydroxyindoleacetic acid and 3‐methoxy‐4‐hydroxyphenylglycol in alcoholics in Finland and the United States
1992
Neurobiology of suicidal behaviour
2003
Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice
1999 StandoutNobel
ANALGESIC AGENTS FOR THE POSTOPERATIVE PERIOD
1999
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Distribution of serotonin 5‐HT1C receptor mRNA in adult rat brain
1989
Organization of the human serotonin transporter gene
1994
Influence of context effects on health outcomes: a systematic review
2001 Standout
Childhood Abuse, Household Dysfunction, and the Risk of Attempted Suicide Throughout the Life Span
2001 Standout
Allelic Variation of Human Serotonin Transporter Gene Expression
1996 Standout
DRD2 Dopamine Receptor Genotype, Linkage Disequilibrium, and Alcoholism in American Indians and Other Populations
1993
The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide
1988 StandoutNobel
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
2002 Standout
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Buspirone, a 5-Hydroxytryptamine1A Agonist, Is Active in Cerebellar Ataxia
1997
Rivers in Practice: Clinicians' Assessments of Patients' Decision-Making Capacity
1989
Neural and developmental actions of lithium: A unifying hypothesis
1989 Standout
Primary structure of the serotonin transporter in unipolar depression and bipolar disorder
1995
Identifying ambulatory cancer patients at risk of impaired capacity to consent to research
2003
Physiological Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
1988
Ethical dilemma. A question of competence
2000
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
1995 StandoutNatureNobel
Suicide
2009
Alcohol and public health
2005 Standout
Examining the link between nonsuicidal self-injury and suicidal behavior: A review of the literature and an integrated model
2012 Standout
The Construct of Resilience: A Critical Evaluation and Guidelines for Future Work
2000 Standout
Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence.
2003 Standout
Cloning and expression of a functional serotonin transporter from rat brain
1991 Nature
An Investigation of Differences Between Self‐Injurious Behavior and Suicide Attempts in a Sample of Adolescents
2004
5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
1995
IDENTIFICATION OF SUICIDE RISK FACTORS USING EPIDEMIOLOGIC STUDIES
1997
Risk for Suicide Attempts Among Adolescents Who Engage in Non-Suicidal Self-Injury
2006
Adolescents with suicidal and nonsuicidal self-harm: Clinical characteristics and response to therapeutic assessment.
2011
Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis
1998
The Role of the Dorsal Hippocampal Serotonergic and Cholinergic Systems in the Modulation of Anxiety
2000
Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease
1993
Distinguishing Between Subgroups of Adolescents Who Self‐Harm
2009
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Assessment of Capacity to Consent to Research Among Older Persons With Schizophrenia, Alzheimer Disease, or Diabetes Mellitus
2005
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Identifying clinically distinct subgroups of self-injurers among young adults: A latent class analysis.
2008
Association between Non-Suicidal Self-Injuries and Suicide Attempts in Chinese Adolescents and College Students: A Cross-Section Study
2011
Self-harm and suicide in adolescents
2012 Standout
The benefits of being present: Mindfulness and its role in psychological well-being.
2003 Standout
Protective and Damaging Effects of Stress Mediators
1998 Standout
Gender differences in completed and attempted suicides
1994
A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation.
1999 Standout
Collaborative Care Management of Late-Life Depression in the Primary Care Setting
2002 Standout
Assessment of Patients' Competence to Consent to Treatment
2007 Standout
Self-Injurious Behavior as a Separate Clinical Syndrome.
2005
5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala
1993
Subgenual prefrontal cortex abnormalities in mood disorders
1997 StandoutNature
Depression in adolescence
2012 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Aging and Hypothalamic-Pituitary-Adrenal Response to Challenge in Humans*
1994
Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration Database
2002
Late-Life Suicide: A Review
1997
Subacute and Chronic In Vivo Lithium Treatment Inhibits Agonist‐ and Sodium Fluoride‐Stimulated Inositol Phosphate Production in Rat Cortex
1989
Multicultural assessment of child and adolescent psychopathology with ASEBA and SDQ instruments: research findings, applications, and future directions
2008 Standout
The neuropathology of aminergic nuclei in Alzheimer's disease
1988
Major Depressive Disorder
2008 Standout
Postmortem Stability of Monoamines, Their Metabolites, and Receptor Binding in Rat Brain Regibns
1994
Identifying Alcoholism Vulnerability Alleles
1995
Assessing Decisional Capacity for Clinical Research or Treatment: A Review of Instruments
2006
A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity
2000
Molecular Basis of Buspirone's Anxiolytic Action
1991
Oxidative stress: Free radical production in neural degeneration
1994
Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets
1994
Serotonin Function and the Mechanism of Antidepressant Action
1990
Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels
2001
Temperature as a dependent variable in the study of cholinergic mechanisms
1988
Assessing Patients' Capacities to Consent to Treatment
1988 Standout
Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention.
1992 Standout
Prediction of Level of Serotonin 2A Receptor Binding by Serotonin Receptor 2A Genetic Variation in Postmortem Brain Samples From Subjects Who Did or Did Not Commit Suicide
1999
Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex
1997
A review of the biochemical and neuropharmacological actions of lithium
1987
The California Scale of Appreciation: A New Instrument to Measure the Appreciation Component of Capacity to Consent to Research
2002
Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders
2000
Impact of Medical Hospitalization on Treatment Decision-Making Capacity in the Elderly
1990
A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs
1985
Mutations in theCaenorhabditis elegansSerotonin Reuptake Transporter MOD-5 Reveal Serotonin-Dependent and -Independent Activities of Fluoxetine
2001 StandoutNobel
Current State of Research on Decision-Making Competence of Cognitively Impaired Elderly Persons
2002
Does informed consent influence therapeutic outcome? A clinical trial of the hypnotic activity of placebo in patients admitted to hospital.
1986
Application of a behavioral theory of motivation to the concepts of anxiety and impulsivity
1987
Reduced fear expression after lesions of the ventral hippocampus
2002 StandoutNobel
Taxonomy and comorbidity of conduct problems: Evidence from empirically based approaches
1993
Informed Consent for Research
1986
Inadequate Functional Health Literacy Among Patients at Two Public Hospitals
1995 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Pivotal mental states
2020
Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action
1978
Neurochemical Correlates of Major Depression in Primary Dementia
1990
Somatic and behavioural postnatal effects of fetal injections of nerve growth factor antibodies in the rat
1981 StandoutNatureNobel
Genetic Dissection of Complex Traits
1994 StandoutScience
The role of nerve-growth factor (NGF) in the central nervous system
1976
Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.
1993
Rapid metabolic evolution in human prefrontal cortex
2011 StandoutNobel
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study
1996
Structure and expression of the rat inositol 1,4,5-trisphosphate receptor.
1990 StandoutNobel
Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brain
1984
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Serotonin receptor knockouts: A moody subject
1998 StandoutNobel
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
2003 StandoutScience
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/BAS Scales.
1994 Standout
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease
2012
Recent Developments in Alcoholism
1987
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Dialectical Behavior Therapy for Borderline Personality Disorder
2002
Cerebral Metabolic Rates for Glucose in Mood Disorders
1985
Competency to Consent to Research
1982
Works of Michael Stanley being referenced
Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
1975
Platelet Imipramine Binding in Children and Adolescents with Impulsive Behavior
1990
Biochemical Studies in Suicide Victims: Current Findings and Future Implications
1989
Association of Aggressive Behavior With Altered Serotonergic Function in Patients Who Are Not Suicidal
2000
Biological Studies and Markers in Suicide and Attempted Suicide
1991
Suicide and the self-harm continuum: phenomenological and biochemical evidence
1992
The benzamides. Pharmacology, neurobiology, and clinical aspects.
1982
Tritiated Imipramine Binding Sites Are Decreased in the Frontal Cortex of Suicides
1982 Science
The Predictive Value of the Dexamethasone Suppression Test
1989
The elderly patient and informed consent. Empirical findings.
1984
Correlations between aminergic metabolites simultaneously obtained from human CSF and brain
1985
Preliminary findings on psychiatric patients as research participants: a population at risk?
1981
Suicide in Schizophrenia
1986
Psychobiology of suicidal behavior.
1986
Postmortem Monoamine Receptor and Enzyme Studies in Suicidea
1986
Neurochemical correlate of body weight in rats
1975
The effect of lithium on rat brain and erythrocyte glycine levels
1981
The Functional Competency of Elderly at Risk1
1988
Effect of chronic lithium on cholinergically mediated responses and [3H]QNB binding in rat brain
1985
INCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS
1983
Postmortem and Regional Changes of Serotonin, 5‐Hydroxyindoleacetic Acid, and Tryptophan in Brain
1984
What Is It? How Is It Assessed? Testing Competency in Psychiatric Patients
1982
Serotonergic mechanisms in the behavioral effects of buspirone and gepirone
1986
The effect of antipsychotic drugs and their clinically inactive analogs on dopamine metabolism
1977
Mental Symptoms in Huntington's Disease and a Possible Primary Aminergic Neuron Lesion
1980 Science
Aging and cortisol resistance to suppression by dexamethasone: A positive correlation
1983
Multiple, single-dose naltrexone administrations fail to effect overall cognitive functioning and plasma cortisol in individuals with probable Alzheimer's disease
1985
Interaction of drug effects with testing procedures in the measurement of catalepsy
1976
Metoclopramide: Antipsychotic efficacy of a drug lacking potency in receptor models
1980